Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Myriad Genetics Inc (MYGN)

33.47 0.33 (1%)

12-15 16:00

Open:

33.19

Pre. Close:

33.14

High:

33.83

Low:

32.89

Volume:

2,748,212

Market Cap:

2317M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

34.07 - 34.38

34.38 - 34.66

Low:

31.93 - 32.31

32.31 - 32.67

Close:

33.18 - 33.79

33.79 - 34.35

Technical analysis  (as of: 2017-12-15 4:58:11 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 40.59     One year: 47.41

Support:

Support1: 32.24    Support2: 30.69

Resistance:

Resistance1: 34.75    Resistance2: 40.59

Pivot:

33.21

Moving Averages:

MA(5): 33.06     MA(20): 33.14

MA(100): 31.92     MA(250): 24.75

MACD:

MACD(12,26): 0.12     Signal(12,26,9): 0.06

%K %D:

%K(14,3): 59.00     %D(3): 48.26

RSI:

RSI(14): 55.09

52-Week:

High: 37.3  Low: 15.15  Change(%): 86.0

Average Vol(K):

3-Month: 88939  10-Days 61776

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MYGN has closed below upper band by 23.8%. Bollinger Bands are 51.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to MYGN's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 05 Dec 2017 12:02:15 GMT
Leadership In Hereditary Cancer Testing Will Drive Myriad Genetics' Stock In 2018

Sun, 17 Dec 2017 00:56:15 GMT
Pinnacle Associates Ltd. Reduces Position in Myriad Genetics, Inc. (NASDAQ:MYGN)

Fri, 08 Dec 2017 22:52:30 GMT
Myriad Genetics Presents Results From Two Important EndoPredict® Studies at ...

Tue, 12 Dec 2017 14:01:12 GMT
Myriad Genetics Will Ride High On The Success Of Its New Molecular Diagnostic ...

Wed, 06 Dec 2017 22:52:30 GMT
Myriad Genetics Presents Pivotal Validation Study for New riskScore™ Test at ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Diagnostic Testing Equipment

Shares Out. (M)

69.24

Shares Float (M)

63.79

% Held by Insiders

1.36

% Held by Institutions

107.90

Shares Short (K)

12840

Shares Short Prior Month (K)

12170

Stock Financials

EPS

1.510

EPS Est. Current Year

1.030

EPS Est. Next Year

1.190

EPS Est. Next Quarter

0.250

Forward EPS

1.220

Book Value (p.s.)

12.590

PEG Ratio

2.66

Profit Margin

13.28

Operating Margin

7.32

Return on Assets (ttm)

2.9

Return on Equity (ttm)

12.9

Qtrly Rev. Growth

7.2

Gross Profit (p.s.)

8.668

Sales Per Share

EBITDA (p.s.)

1.584

Qtrly Earnings Growth

Operating Cash Flow (M)

132.60

Levered Free Cash Flow (M)

167.30

atoplab.com

Valuation

P/E

22.40

P/E Growth Ratio

0.02

P/BV

2.69

P/S

203803024.00

P/CF

17.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

2009-01-07

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.